The TGA described the vials as "substandard semaglutide" and revealed testing found the vials contained 10 times the amount of vitamin B12 on the label
Some patients experience intolerable GI side effects or cant use GLP-1 drugs due to medical contraindications
Preclinical studies suggests BPC 157 has the following effects: Reduced inflammation of the gut and enhanced repair of the intestinal lining
Developmental Delays in Infants Infants born to B12-deficient mothers may show delays in motor skills, alertness, and feeding, especially in exclusively breastfed babies [*]
Product Information BPC-157 Overview BPC-157, also known as Body Protection Compound 157, is a synthetic peptide derived from a naturally occurring protein found in human gastric juice
With FDA input pending, the companies are targeting a Phase 3 trial launch in the first half of 2026